ZTEK Stock Overview
Engages in the research and development of graphene and related nanomaterials in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Zentek Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.71 |
| 52 Week High | CA$1.59 |
| 52 Week Low | CA$0.70 |
| Beta | 0.84 |
| 11 Month Change | -26.61% |
| 3 Month Change | -32.35% |
| 1 Year Change | -43.40% |
| 33 Year Change | -82.60% |
| 5 Year Change | 145.69% |
| Change since IPO | 119.91% |
Recent News & Updates
Shareholder Returns
| ZTEK | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -6.5% | -0.6% | 0.9% |
| 1Y | -43.4% | 20.8% | 32.3% |
Return vs Industry: ZTEK underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: ZTEK underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| ZTEK volatility | |
|---|---|
| ZTEK Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ZTEK's share price has been volatile over the past 3 months.
Volatility Over Time: ZTEK's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 24 | Greg Fenton | www.zentek.com |
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis.
Zentek Ltd. Fundamentals Summary
| ZTEK fundamental statistics | |
|---|---|
| Market cap | US$73.91m |
| Earnings (TTM) | -US$8.21m |
| Revenue (TTM) | US$26.12k |
2,830x
P/S Ratio-9.0x
P/E RatioIs ZTEK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZTEK income statement (TTM) | |
|---|---|
| Revenue | CA$35.31k |
| Cost of Revenue | CA$423.02k |
| Gross Profit | -CA$387.71k |
| Other Expenses | CA$10.71m |
| Earnings | -CA$11.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | -1,098.18% |
| Net Profit Margin | -31,443.53% |
| Debt/Equity Ratio | 3.5% |
How did ZTEK perform over the long term?
See historical performance and comparison